These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 7310249)

  • 1. Pulse therapy in severe form of dengue shock syndrome.
    Futrakul P; Vasanauthana S; Poshyachinda M; Mitrakul C; Cherdboonchart V; Kanthirat V
    J Med Assoc Thai; 1981 Oct; 64(10):485-91. PubMed ID: 7310249
    [No Abstract]   [Full Text] [Related]  

  • 2. Hemodynamic response to high-dose methyl prednisolone and mannitol in severe dengue-shock patients unresponsive to fluid replacement.
    Futrakul P; Poshyachinda M; Mitrakul C; Kwakpetoon S; Unchumchoke P; Teranaparin C; Kheokham K; Impand C
    Southeast Asian J Trop Med Public Health; 1987 Sep; 18(3):373-9. PubMed ID: 3124276
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Failure of high-dose methylprednisolone in established dengue shock syndrome: a placebo-controlled, double-blind study.
    Tassniyom S; Vasanawathana S; Chirawatkul A; Rojanasuphot S
    Pediatrics; 1993 Jul; 92(1):111-5. PubMed ID: 8516054
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of steroids in dengue shock syndrome.
    Sumarmo
    Southeast Asian J Trop Med Public Health; 1987 Sep; 18(3):383-9. PubMed ID: 3324364
    [No Abstract]   [Full Text] [Related]  

  • 5. [Hemorrhagic fever and the dengue shock syndrome].
    Ramos C; García H; Villaseca JM
    Salud Publica Mex; 1993; 35(1):39-55. PubMed ID: 8470020
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Early differentiation between dengue and septic shock by comparison of admission hemodynamic, clinical, and laboratory variables: a pilot study.
    Ranjit S; Kissoon N; Gandhi D; Dayal A; Rajeshwari N; Kamath SR
    Pediatr Emerg Care; 2007 Jun; 23(6):368-75. PubMed ID: 17572519
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Colloid oncotic pressure in severe dengue shock syndrome.
    Hassan R; Chair I; Darwis D; Latief A
    Paediatr Indones; 1986; 26(11-12):213-9. PubMed ID: 3562035
    [No Abstract]   [Full Text] [Related]  

  • 8. Pathophysiology and therapy of mosquito-borne hemorrhagic fever in Thailand.
    Cohen SN
    Jpn J Med Sci Biol; 1967 Dec; 20 Suppl():90-5. PubMed ID: 5301573
    [No Abstract]   [Full Text] [Related]  

  • 9. [Hemorrhagic dengue with shock in children in French Polynesia].
    Mallet EC; Gestas P; Pilorget H; Bataille H
    Bull Soc Pathol Exot; 1993; 86(5 Pt 2):450-4. PubMed ID: 7819799
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Studies on the pathogenesis of dengue hemorrhagic fever: Hemodynamic alteration and effect of alpha blocking agent.
    Futrakul P; Mitrakul C; Chumdermpadetsuk S; Sitprija V
    J Med Assoc Thai; 1977 Dec; 60(12):610-4. PubMed ID: 24079
    [No Abstract]   [Full Text] [Related]  

  • 11. Corticosteroids in the treatment of dengue illness.
    Rajapakse S
    Trans R Soc Trop Med Hyg; 2009 Feb; 103(2):122-6. PubMed ID: 18789467
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transfusion support to Dengue patients in a hospital based blood transfusion service in north India.
    Chaudhary R; Khetan D; Sinha S; Sinha P; Sonker A; Pandey P; Das SS; Agarwal P; Ray V
    Transfus Apher Sci; 2006 Dec; 35(3):239-44. PubMed ID: 17097349
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Repeated dengue shock syndrome and 'dengue myocarditis' responding dramatically to a single dose of methyl prednisolone.
    Premaratna R; Rodrigo KM; Anuratha A; de Alwis VK; Perera UD; de Silva HJ
    Int J Infect Dis; 2012 Jul; 16(7):e565-9. PubMed ID: 22521778
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hydrocortisone in the management of dengue shock syndrome.
    Min M; U T; Aye M; Shwe TN; Swe T
    Southeast Asian J Trop Med Public Health; 1975 Dec; 6(4):573-9. PubMed ID: 131976
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aggressive management of dengue shock syndrome may decrease mortality rate: a suggested protocol.
    Ranjit S; Kissoon N; Jayakumar I
    Pediatr Crit Care Med; 2005 Jul; 6(4):412-9. PubMed ID: 15982427
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dengue shock syndrome. An evaluation of clinical experiences.
    Munir M; Rampengan TH
    Paediatr Indones; 1984; 24(11-12):254-64. PubMed ID: 6537475
    [No Abstract]   [Full Text] [Related]  

  • 17. Primary dengue infection: what are the clinical distinctions from secondary infection?
    Pancharoen C; Mekmullica J; Thisyakorn U
    Southeast Asian J Trop Med Public Health; 2001 Sep; 32(3):476-80. PubMed ID: 11944702
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Profile of pediatric dengue cases from a tertiary care hospital in Kolkata.
    Basu M; Dasgupta MK; Kundu TK; Sengupta B; De GK; Roy BN
    Indian J Public Health; 2007; 51(4):234-6. PubMed ID: 18232165
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transfusion requirements in patients with dengue hemorrhagic fever.
    Chuansumrit A; Phimolthares V; Tardtong P; Tapaneya-Olarn C; Tapaneya-Olarn W; Kowsathit P; Chantarojsiri T
    Southeast Asian J Trop Med Public Health; 2000 Mar; 31(1):10-4. PubMed ID: 11023057
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vascular leakage in dengue--clinical spectrum and influence of parenteral fluid therapy.
    Rosenberger KD; Lum L; Alexander N; Junghanss T; Wills B; Jaenisch T;
    Trop Med Int Health; 2016 Mar; 21(3):445-53. PubMed ID: 26752720
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.